Key result
Antiarrhythmics temporarily stabilize pediatric arrhythmogenic cardiomyopathy before disease progression requires an ICD.
Why the study?
Arrhythmogenic cardiomyopathy/right ventricular dysplasia is rarely diagnosed and seldom debuts in the prepubertal period, presenting diagnostic difficulties at this age.
Case Report (n=1)
Highlights the diagnostic challenges and progressive nature of arrhythmogenic cardiomyopathy in the pediatric population.
Case reports of prepubertal arrhythmogenic cardiomyopathy warrant diagnostic vigilance in adolescents with ventricular ectopy; leaves open need for pediatric registries.
Arrhythmogenic cardiomyopathy/right ventricular dysplasia is a rarely diagnosed hereditary cardiomyopathy that seldom debuts in the prepubertal period. Therefore, its diagnosis at this ages certain difficulties. We present a clinical case of this disease, which we have been observing for 6 years. The first symptoms of the disease in a thirteen years old teenager were ventricular premature beats that detected during a routine electrocardiographic examination. The presence of deep negative T waves in leads V1–V3 on the ECG, the presence of stress induced of polymorphic ventricular tachycardia, the appearance of additional markers of electrical instability of the myocardium during Holter monitoring (heart rate turbulence, microvolt alternans) and ventricular late potentials made it possible to suspect and then confirm a rare cardiomyopathy – arrhythmogenic cardiomyopathy during an MRI examination of the heart. The antiarrhythmic therapy allowed stabilizing the patient’s condition. However, at the age of 18, the disease progressed with inadequate intake of drugs, episodes of loss of consciousness appeared, and a cardioverter defibrillator was implanted in the patient. The presented case of observation of a patient with cardiomyopathy, rare for the pediatric population, with a progressive unfavorable course of the disease, the use of modern diagnostic methods made it possible to identify the unfavorable nature of arrhythmia, quickly make a diagnosis and prescribe therapy that prevented the development of syncopal episodes in childhood.
No takes yet. Share an insight, caveat, or question.
Комолятова et al. (2025) conducted a case report in Arrhythmogenic cardiomyopathy (n=1). Antiarrhythmic therapy and cardioverter defibrillator was evaluated on Clinical course and symptom progression. Antiarrhythmic therapy initially stabilized a 13-year-old with arrhythmogenic cardiomyopathy, but disease progression by age 18 required cardioverter defibrillator implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: